Pharmaceutical News and Articles

Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer

Tokyo and Basking Ridge, NJ (October 30, 2024) The first patients have been dosed in three global, randomized phase 3 trials evaluating the efficacy and safety

Protega Pharmaceuticals Receives FDA Approval for RoxyBond (oxycodone hydrochloride) Immediate-Release 10 mg Tablet with Abuse-Deterrent Technology for Management of Pain

Novartis Scemblix Granted FDA Accelerated Approval in Newly Diagnosed CML

Shorla Oncology Announces U.S. FDA Expanded Approval of Jylamvo (methotrexate), an Oncology and Autoimmune Drug for Pediatric Indications

Causal Relationship Seen Between GERD and Hypertension

There is a positive causal relationship between gastroesophageal reflux disease (GERD) and hypertension, according to a study published online Sept. 23 in Front

Global TB Cases Hit Record High, TB Becomes Top Infectious Disease Killer

The World Health Organization reports that tuberculosis (TB) cases hit a record high in 2023, with more than 8 million diagnoses and 1.25 million deaths, meanin

Exercise Cuts Dependence in Those With Alcohol Use Disorder

An exercise intervention can effectively reduce alcohol dependence in patients with alcohol use disorder (AUD), according to a review published online Oct. 30 i

Flu-Linked Hospitalization Rates Vary Across Seasons, Highest in Adults 65+

Influenza-associated hospitalization rates vary across seasons, and only returned to recent pre-COVID-19 pandemic levels in the 2022-2023 influenza season, acco

Generic Medications Can Keep OOP Costs Down for Neurological Conditions

Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, for which costs continue to increase

Late-Life Menopause Linked to Higher Asthma Risk

Women who enter menopause at a later age have a greater risk of asthma, a new study says. Meanwhile, early menopause is associated with a reduced risk of develo